These findings demonstrate the importance of targeting the lipid metabolism pathway, utilizing GPX4 inhibitors, and exploring synergistic effects with other compounds to overcome resistance and enhance ferroptosis in melanoma treatment. Here, GPX4 is linked to melanoma.